All Stories

  1. The Novel Activity of Carbamazepine as an Activation Modulator Extends from NaV1.7 Mutations to the NaV1.8-S242T Mutant Channel from a Patient with Painful Diabetic Neuropathy

    Article • Molecular Pharmacology, August 2018, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Sulayman Dib-Hajj

  2. Differential aging-related changes in neurophysiology and gene expression in IB4-positive and IB4-negative nociceptive neurons

    Article • Aging Cell, June 2018, Wiley

    Sulayman Dib-Hajj

  3. Nonmuscle myosin II isoforms interact with sodium channel alpha subunits

    Article • Molecular Pain, January 2018, SAGE Publications

    Sulayman Dib-Hajj

  4. Reverse pharmacogenomics: carbamazepine normalizes activation and attenuates thermal hyperexcitability of sensory neurons due to Nav 1.7 mutation I234T

    Article • British Journal of Pharmacology, July 2017, Wiley

    Sulayman Dib-Hajj, Roberta Gualdani